Dr. Chen specializes in neuromodulation therapies—transcranial magnetic stimulation (TMS), MR-guided focused ultrasound (MRgFUS), and botulinum toxin—for conditions such as Parkinson’s disease, dystonia, stroke, and dementia. The team leads the clinical application and academic development of MRgFUS for movement disorders, particularly Parkinson’s disease and essential tremor. We pioneered a stepwise dual-target strategy (PTT + VIM) to treat both tremor and rigidity with high precision and minimal invasiveness. Our research explores brain stimulation mechanisms, multimodal neuroimaging, and outcomes of non-invasive therapies. The team actively engages in international clinical trials and collaborations.

Professor Tsai is the current Dean of the College of Medicine at China Medical University and the Director of the Neurology Department at its affiliated hospital. He has served as the President of the Taiwan Movement Disorder Society and as a council member of the International Parkinson's and Movement Disorder Society for the Asia-Pacific region. Professor Tsai is an expert in clinical neurophysiology and involuntary movement disorders, specializing in the application of neurophysiological modulation and focused ultrasound treatment for Parkinson's patients. In addition to his clinical work and research, he is also deeply committed to medical education. He was awarded the 2020 Taiwan Medical Model Award.

Professor Lee is the current Dean of the College of Healthcare and an attending physician in the Department of Neurology at China Medical University Hospital. Professor Lee is an expert in Wilson's disease.

Assistant Professor Chung-Hsiang Liu is an attending physician in the Stroke and Neurocritical Care Unit of the Department of Neurology at China Medical University Hospital. He is dedicated to treating stroke patients and providing comprehensive care for stroke patients

Professor Woei-Cheang Shyu is the Vice President of China Medical University Hospital and an attending physician in the Neurology Department. He has long been dedicated to research in neuroimmunology, stem cells, exosomes, and basic neurology. He is one of the few neurologists with a strong foundation in basic neuroscience research. His work in translating stem cell research into clinical treatment is unparalleled globally and has significantly benefited patients. With his support, there are currently Phase I clinical research projects underway in the Neurology Department for subacute ischemic stroke and multiple sclerosis, making him a key driver of innovation and breakthroughs in neurology.

Wei-Shih Huang is an attending physician in the Stroke and Neurocritical Care Unit of the Department of Neurology at China Medical University Hospital. He is dedicated to the treatment of stroke patients, stroke prevention and control of risk factors (such as hypertension, diabetes, and hyperlipidemia), and comprehensive care for stroke patients. He also specializes in cerebrovascular ultrasound examinations.

Doctor Chun-Hung Tseng was a Research Fellow at University of Sydney. He transferred to the hospital in 2001 and has been working here ever since. Currently he is a part-time instructor at our school who specializes in peripheral nerve, headaches, Fasciæ musculares discomfort syndrome and peripheral nerve system physical examination (neural transmission and electromyogram [close to 3000 cases a year]). Doctor Chun-Hung Tseng is familiar with neuroimmunology and Neural Epidemiology and has rich experiences in teaching.

Dr. Lin is the Director of the Stroke and Neurocritical Care Unit in the Department of Neurology at China Medical University Hospital, where he has been responsible for the care of patients in the Stroke and Neurocritical Care Unit for nearly twenty years. He is currently a board member of the Taiwan Neurocritical Care Society. Dr. Lin also specializes in the diagnosis and treatment of headache disorders and currently serves as a board member of the Taiwan Headache Society.

Associate Professor Ming-Kuei Lu is the Director of the Parkinson's and Movement Disorders Department at the China Medical University Hospital. He is dedicated to exploring the pathogenic mechanisms of Parkinson's and movement disorders through neurophysiology. He also specializes in treating Parkinson's patients using deep brain stimulation and focused ultrasound. Dr. Lu currently serves as the President of the Clinical Neurophysiology Society and is an internationally recognized expert in neurophysiology, frequently invited to speak at international academic conferences, enhancing Taiwan's visibility in the global academic community.

Assistant Professor Yang Yu-Wan is the Director of the General Neurology and Dementia Section in the Department of Neurology at China Medical University Hospital. She specializes in neurodegenerative diseases (such as dementia with depression, delusions, Parkinson's disease), stroke prevention and risk factor control (such as diabetes, hypertension, hyperlipidemia), headache, epilepsy, etc.